Dr. Lal Path Labs Ltd. Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Excellent return on equity (ROE 22.3%)
- ✓Efficient capital deployment (ROCE 28%)
- ✓Virtually debt-free
Concerns
- ✗High premium to book value (P/B 11.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
LALPATHLAB · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 54.60% | 54.60% | 54.60% | 53.92% | 53.91% | 53.91% |
| FII | 25.36% | 26.15% | 25.43% | 26.82% | 26.82% | 23.90% |
| DII | 9.27% | 9.40% | 12.42% | 12.60% | 12.88% | 15.79% |
| Public | 10.12% | 9.24% | 6.95% | 6.02% | 5.82% | 5.84% |
| Govt | 0.29% | 0.29% | 0.29% | 0.29% | 0.29% | 0.29% |
| Others | 0.37% | 0.32% | 0.30% | 0.33% | 0.28% | 0.27% |
Corporate Events
To consider Interim dividend for FY 2026-27, if any,
To consider and approve the financial results for the period ending Jun 30, 2026 and other business mattersPlease note that this Board Meeting pertains to the Financial Year 2026 2027. However, while submitting this announcement, the Financial Year is bei
Dividend - Rs 4 Per Share
Record: 25 Jun 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and recommend Final Dividend for FY 2025-26, if any
Interim Dividend - Rs 3.50 Per Share
Bonus 1:1
Interim Dividend - Rs 7 Per Share
Interim Dividend - Rs 6 Per Share
Dividend - Rs 6 Per Share
Latest News
All news →Dr. Lal Path Labs publishes statutory notice
*Dr. Lal Path Labs publishes statutory notice* Dr. Lal Path Labs Ltd. has submitted a copy of its newspaper publication to the exchange as part of regulatory compliance. The filing does not disclose any financial or operational update. Such disclosures are routine and typically informational in nature. 📊 *STOCKS:* LALPATHLAB | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #corporatefiling
Dr. Lal Path Labs submits sustainability report for FY 2025-26
*Dr. Lal Path Labs submits sustainability report for FY 2025-26.* The company has filed its Business Responsibility and Sustainability Report with the NSE. This is a routine regulatory disclosure and does not contain financial or operational updates. Such filings are part of ongoing compliance requirements. 📊 *STOCKS:* DRLALPATH | 🏢 *SECTOR:* Corporate | #LOWIMPACT #Sustainability
Dr. Lal Path Labs to hold AGM on July 25, 2026
*Dr. Lal Path Labs to hold AGM on July 25, 2026.* The company has informed the exchange about the notice of its Annual General Meeting. This is a routine corporate exercise with no immediate financial impact. Investors may expect updates on business performance and governance. 📊 *STOCKS:* LALPATHLAB | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #CorporateEvent
Dr. Lal Path Labs publishes newspaper notice
*Dr. Lal Path Labs publishes newspaper notice.* The company has submitted a copy of its newspaper publication to the exchange as part of regulatory compliance. This is a routine disclosure with no immediate financial implications. **No monetary figure** or strategic update was disclosed. 📊 *STOCKS:* LALPATHLAB | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #corporate
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹660 Cr ▼9.7% | ₹731 Cr ▲9.1% | ₹670 Cr ▲11.1% | ₹603 Cr ▲1.0% | ₹597 Cr ▼9.5% | ₹660 Cr ▲9.6% | ₹602 Cr ▲10.5% | ₹545 Cr |
| Op. Profit | ₹179 Cr ▼20.1% | ₹224 Cr ▲16.7% | ₹192 Cr ▲13.6% | ₹169 Cr ▲9.7% | ₹154 Cr ▼23.8% | ₹202 Cr ▲18.8% | ₹170 Cr ▲17.2% | ₹145 Cr |
| OPM | 27.0% ▼12.9% | 31.0% ▲6.9% | 29.0% ▲3.6% | 28.0% ▲7.7% | 26.0% ▼16.1% | 31.0% ▲10.7% | 28.0% ▲3.7% | 27.0% |
| Net Profit | ₹91 Cr ▼40.1% | ₹152 Cr ▲13.4% | ₹134 Cr ▼14.1% | ₹156 Cr ▲59.2% | ₹98 Cr ▼25.2% | ₹131 Cr ▲21.3% | ₹108 Cr ▲25.6% | ₹86 Cr |
| EPS (₹) | 5.4 ▼39.9% | 8.99 ▲13.8% | 7.9 ▼14.7% | 9.26 ▲60.2% | 5.78 ▼25.2% | 7.73 ▲21.4% | 6.37 ▲25.9% | 5.06 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2.8K Cr ▲12.3% | ₹2.5K Cr ▲10.5% | ₹2.2K Cr ▲10.4% | ₹2.0K Cr ▼3.4% | ₹2.1K Cr ▲32.0% | ₹1.6K Cr ▲18.9% | ₹1.3K Cr ▲10.6% | ₹1.2K Cr ▲13.8% | ₹1.1K Cr ▲15.9% | ₹912 Cr |
| Expenses | ₹2.0K Cr ▲12.2% | ₹1.8K Cr ▲9.1% | ₹1.6K Cr ▲5.9% | ₹1.5K Cr ▲0.1% | ₹1.5K Cr ▲33.3% | ₹1.1K Cr ▲16.0% | ₹987 Cr ▲8.5% | ₹910 Cr ▲14.8% | ₹793 Cr ▲17.5% | ₹675 Cr |
| Op. Profit | ₹783 Cr ▲12.2% | ₹698 Cr ▲14.6% | ₹609 Cr ▲24.3% | ₹490 Cr ▼12.7% | ₹561 Cr ▲28.7% | ₹436 Cr ▲26.7% | ₹344 Cr ▲17.0% | ₹294 Cr ▲11.4% | ₹264 Cr ▲10.9% | ₹238 Cr |
| OPM | 28.0% ▲0.0% | 28.0% ▲3.7% | 27.0% ▲12.5% | 24.0% ▼11.1% | 27.0% ▼3.6% | 28.0% ▲7.7% | 26.0% ▲8.3% | 24.0% ▼4.0% | 25.0% ▼3.8% | 26.0% |
| Other Income | ₹70 Cr ▼23.1% | ₹91 Cr ▲31.9% | ₹69 Cr ▲64.3% | ₹42 Cr ▼19.2% | ₹52 Cr ▲2.0% | ₹51 Cr ▼7.3% | ₹55 Cr ▲19.6% | ₹46 Cr ▲48.4% | ₹31 Cr ▲14.8% | ₹27 Cr |
| Interest | ₹23 Cr ▲4.5% | ₹22 Cr ▼24.1% | ₹29 Cr ▼23.7% | ₹38 Cr ▲26.7% | ₹30 Cr ▲87.5% | ₹16 Cr ▲6.7% | ₹15 Cr ▲1400.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▲0.0% | ₹1 Cr |
| Depreciation | ₹162 Cr ▲14.1% | ₹142 Cr ▼1.4% | ₹144 Cr ▼4.0% | ₹150 Cr ▲38.9% | ₹108 Cr ▲40.3% | ₹77 Cr ▲5.5% | ₹73 Cr ▲92.1% | ₹38 Cr ▲15.2% | ₹33 Cr ▲17.9% | ₹28 Cr |
| PBT | ₹669 Cr ▲7.0% | ₹625 Cr ▲23.8% | ₹505 Cr ▲46.8% | ₹344 Cr ▼27.6% | ₹475 Cr ▲20.6% | ₹394 Cr ▲27.1% | ₹310 Cr ▲3.0% | ₹301 Cr ▲15.3% | ₹261 Cr ▲10.1% | ₹237 Cr |
| Tax % | 24.0% ▲14.3% | 21.0% ▼25.0% | 28.0% ▼6.7% | 30.0% ▲15.4% | 26.0% ▲4.0% | 25.0% ▼7.4% | 27.0% ▼18.2% | 33.0% ▼2.9% | 34.0% ▲0.0% | 34.0% |
| Net Profit | ₹510 Cr ▲3.7% | ₹492 Cr ▲35.9% | ₹362 Cr ▲50.2% | ₹241 Cr ▼31.1% | ₹350 Cr ▲18.2% | ₹296 Cr ▲29.8% | ₹228 Cr ▲14.0% | ₹200 Cr ▲16.3% | ₹172 Cr ▲10.3% | ₹156 Cr |
| EPS (₹) | 30.13 ▲3.4% | 29.14 ▲36.0% | 21.42 ▲49.5% | 14.33 ▼30.7% | 20.69 ▲18.3% | 17.49 ▲29.1% | 13.55 ▲13.4% | 11.95 ▲16.7% | 10.24 ▲10.0% | 9.31 |
| Div Payout | 68.0% ▲65.9% | 41.0% | 0.0% ▼100.0% | 42.0% ▲44.8% | 29.0% ▼49.1% | 57.0% ▲29.5% | 44.0% ▲76.0% | 25.0% ▲13.6% | 22.0% ▲37.5% | 16.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹84 Cr ▲0.0% | ₹84 Cr ▲1.2% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr |
| Reserves | ₹2.3K Cr ▲10.3% | ₹2.1K Cr ▲18.3% | ₹1.8K Cr ▲11.6% | ₹1.6K Cr ▲11.6% | ₹1.4K Cr ▲22.0% | ₹1.2K Cr ▲22.4% | ₹949 Cr ▲10.1% | ₹862 Cr ▲22.3% | ₹705 Cr ▲37.7% | ₹512 Cr |
| Borrowings | ₹156 Cr ▼0.6% | ₹157 Cr ▼36.4% | ₹247 Cr ▼41.2% | ₹420 Cr ▼21.2% | ₹533 Cr ▲255.3% | ₹150 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Liabilities | ₹415 Cr ▲8.4% | ₹383 Cr ▲7.3% | ₹357 Cr ▲20.2% | ₹297 Cr ▼3.9% | ₹309 Cr ▲16.6% | ₹265 Cr ▼22.3% | ₹341 Cr ▲135.2% | ₹145 Cr ▲13.3% | ₹128 Cr ▲34.7% | ₹95 Cr |
| Total Liabilities | ₹3.0K Cr ▲9.1% | ₹2.7K Cr ▲10.6% | ₹2.5K Cr ▲3.0% | ₹2.4K Cr ▲1.7% | ₹2.3K Cr ▲41.1% | ₹1.7K Cr ▲20.9% | ₹1.4K Cr ▲25.9% | ₹1.1K Cr ▲19.1% | ₹916 Cr ▲32.8% | ₹690 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹1.2K Cr ▲5.5% | ₹1.2K Cr ▼4.9% | ₹1.2K Cr ▼5.9% | ₹1.3K Cr ▼4.7% | ₹1.4K Cr ▲206.3% | ₹447 Cr ▲8.2% | ₹413 Cr ▲97.6% | ₹209 Cr ▲0.5% | ₹208 Cr ▲36.8% | ₹152 Cr |
| CWIP | ₹17 Cr ▲466.7% | ₹3 Cr ▼50.0% | ₹6 Cr ▲20.0% | ₹5 Cr ▼66.7% | ₹15 Cr ▲50.0% | ₹10 Cr ▼9.1% | ₹11 Cr ▲266.7% | ₹3 Cr ▼70.0% | ₹10 Cr ▼44.4% | ₹18 Cr |
| Investments | ₹486 Cr ▲48.6% | ₹327 Cr ▲186.8% | ₹114 Cr ▼24.0% | ₹150 Cr ▲130.8% | ₹65 Cr ▲10.2% | ₹59 Cr ▼64.0% | ₹164 Cr ▼11.4% | ₹185 Cr ▲27.6% | ₹145 Cr ▲36.8% | ₹106 Cr |
| Other Assets | ₹1.2K Cr ▲0.8% | ₹1.2K Cr ▲9.8% | ₹1.1K Cr ▲19.9% | ₹923 Cr ▲3.4% | ₹893 Cr ▼21.9% | ₹1.1K Cr ▲45.5% | ₹786 Cr ▲13.3% | ₹694 Cr ▲25.3% | ₹554 Cr ▲33.8% | ₹414 Cr |
| Total Assets | ₹3.0K Cr ▲9.1% | ₹2.7K Cr ▲10.6% | ₹2.5K Cr ▲3.0% | ₹2.4K Cr ▲1.7% | ₹2.3K Cr ▲41.1% | ₹1.7K Cr ▲20.9% | ₹1.4K Cr ▲25.9% | ₹1.1K Cr ▲19.1% | ₹916 Cr ▲32.8% | ₹690 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹569 Cr ▲6.4% | ₹535 Cr ▲17.3% | ₹456 Cr ▲2.0% | ₹447 Cr ▲12.3% | ₹398 Cr ▲40.1% | ₹284 Cr ▲29.7% | ₹219 Cr ▲11.2% | ₹197 Cr ▲15.2% | ₹171 Cr ▲7.5% | ₹159 Cr |
| Investing CF | ₹-303 Cr ▼1162.5% | ₹-24 Cr ▲91.6% | ₹-287 Cr ▲36.1% | ₹-449 Cr ▼111.8% | ₹-212 Cr ▼715.4% | ₹-26 Cr ▲74.0% | ₹-100 Cr ▲41.9% | ₹-172 Cr ▼25.5% | ₹-137 Cr ▲16.0% | ₹-163 Cr |
| Financing CF | ₹-334 Cr ▲19.3% | ₹-414 Cr ▼46.3% | ₹-283 Cr ▼308.1% | ₹136 Cr ▲197.8% | ₹-139 Cr ▲26.8% | ₹-190 Cr ▼245.5% | ₹-55 Cr ▼523.1% | ₹13 Cr ▲140.6% | ₹-32 Cr | ₹0 Cr |
| Net Cash Flow | ₹-68 Cr ▼170.1% | ₹97 Cr ▲185.1% | ₹-114 Cr ▼185.1% | ₹134 Cr ▲179.2% | ₹48 Cr ▼28.4% | ₹67 Cr ▲4.7% | ₹64 Cr ▲73.0% | ₹37 Cr ▲1750.0% | ₹2 Cr ▲140.0% | ₹-5 Cr |
| Free Cash Flow | ₹516 Cr ▲7.7% | ₹479 Cr ▲16.3% | ₹412 Cr ▲1571.4% | ₹-28 Cr ▼108.3% | ₹339 Cr ▲65.4% | ₹205 Cr ▲15.8% | ₹177 Cr ▲41.6% | ₹125 Cr ▲4.2% | ₹120 Cr ▲4.3% | ₹115 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 13d ▲0.0% | 13d ▲0.0% | 13d ▼13.3% | 15d ▲0.0% | 15d ▲7.1% | 14d ▼12.5% | 16d ▲14.3% | 14d ▼17.6% | 17d ▲0.0% | 17d |
| Inventory Days | 27d ▼10.0% | 30d ▲7.1% | 28d ▼26.3% | 38d ▼2.6% | 39d ▼44.3% | 70d ▲75.0% | 40d ▼9.1% | 44d ▲33.3% | 33d ▲6.5% | 31d |
| Days Payable | 127d ▼15.9% | 151d ▲18.9% | 127d ▲18.7% | 107d ▼18.9% | 132d ▼8.3% | 144d ▲29.7% | 111d ▲4.7% | 106d ▲9.3% | 97d ▲9.0% | 89d |
| Cash Conv. Cycle | -86d ▲20.4% | -108d ▼24.1% | -87d ▼61.1% | -54d ▲30.8% | -78d ▼30.0% | -60d ▼9.1% | -55d ▼17.0% | -47d ▲0.0% | -47d ▼11.9% | -42d |
| Working Capital Days | -30d ▲34.8% | -46d ▲17.9% | -56d ▼3.7% | -54d ▼107.7% | -26d ▼36.8% | -19d | 0d ▼100.0% | 17d ▼10.5% | 19d ▼29.6% | 27d |
| ROCE | 29.0% ▲16.0% | 25.0% ▲38.9% | 18.0% ▼37.9% | 29.0% ▼12.1% | 33.0% ▲3.1% | 32.0% ▼8.6% | 35.0% ▼7.9% | 38.0% ▼11.6% | 43.0% ▼8.5% | 47.0% |
Source: Screener.in · Lower days = better efficiency